مباشر

FierceBiotechAfter Arcellx buyout close, Gilead trims 108 jobs at CAR-T biotech's Redwood City outpost FDA News ReleasesFDA Expands Market Access, Authorizes New ENDS Products Endpoints NewsIntercept's next-gen FXR agonist fails Phase 2 in latest setback for Italian-owned pharma Clinical OMICsMuscle Quality and Fat Distribution Predict Mortality Risk Better than BMI Endpoints NewsPfizer's Albert Bourla says he has no mega-merger plans Clinical OMICsGenotype-Guided Antidepressants Could Have Long-Term Benefits ModernaBoston biotech firms back new effort to preserve U.S. edge in life sciences - The Business Journals RevvityRevvity Outperforms in Q1 2026 Driven by Pharma Rebound and Strategic Portfolio Shifts - Lab Manager Endpoints NewsBioNTech to scale down manufacturing, over 1,800 jobs on the line Endpoints NewsParsley Health goes in-network nationwide RevvityWhy Is Revvity (RVTY) Stock Rocketing Higher Today - TradingView PfizerPfizer beats estimates but investors cautious - The Pharma Letter

Endpoints News ٥ مايو ٢٠٢٦

BioNTech to scale down manufacturing, over 1,800 jobs on the line

BioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff c...

BioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downsizing ...